|
HS Code |
106286 |
| Product Name | 2,6-Bis(Benzyloxy)-3-Bromopyridine |
| Cas Number | 883531-85-7 |
| Molecular Formula | C24H20BrNO2 |
| Molecular Weight | 434.33 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Boiling Point | Decomposes |
| Solubility | Soluble in organic solvents like DMSO and dichloromethane |
| Storage Temperature | 2-8°C, protect from light and moisture |
| Smiles | Brc1c(OCc2ccccc2)nc(OCc3ccccc3)cc1 |
| Inchi | InChI=1S/C24H20BrNO2/c25-21-17-23(27-15-19-9-5-2-6-10-19)13-14-24(26-21)28-16-20-11-7-3-4-8-12-20/h2-14,17H,15-16H2 |
As an accredited 2,6-Bis(Benzyloxy)-3-Bromopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,6-Bis(Benzyloxy)-3-Bromopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Researchers and product developers know that certain building blocks can transform the pace and quality of organic synthesis. 2,6-Bis(Benzyloxy)-3-Bromopyridine stands out for those who understand the value of precision, reliability, and performance in the lab. Plenty of chemicals claim to streamline synthesis routes, but not every compound can offer the range and adaptability found in this molecule. Chemists tackling the challenges of pharmaceutical intermediates or specialty organics can leverage it for its adaptability in various transformations.
Let’s look at what puts 2,6-Bis(Benzyloxy)-3-Bromopyridine in a league of its own. Its structure – a pyridine ring outfitted with a bromine atom at the 3-position and benzyloxy groups at the 2 and 6 positions – makes it a magnet for selective reactions. The benzyloxy groups protect the reactive sites, allowing researchers to control their synthesis experiments with more finesse. In practice, these protective groups survive many conditions that would compromise less robust intermediates, and once the desired transformation is complete, standard deprotection steps bring you back to the free pyridine functionality. Laboratory teams aiming for high yield and reproducibility in coupling reactions find themselves reaching time after time for this compound.
Thinking back on my own time working with aromatic bromides, stability and compatibility always sat at the top of my checklist. Fewer contaminants slip in with a compound engineered for clean extraction and rigorous purification. I remember once struggling to scale up a reaction where the precursor kept breaking down, leading to more column runs than anyone on a graduate stipend wants to pay for. When a colleague introduced me to bis-benzyloxy-protected pyridines, the downstream steps finally clicked: purification became less about fighting decomposition and more about maximizing throughput. Over several years in contract synthesis labs, stories like this came up often—switching from lower-grade intermediates to ones like 2,6-bis(benzyloxy)-3-bromopyridine didn’t just save time, it meant cleaner final products and less hair-pulling over quality checks.
Chemists face a tough decision with every intermediate they choose. In a world full of pyridine derivatives, why stop to consider this one?
The backbone of modern pharmaceuticals often starts with heterocycles precisely tailored to a task. Pyridines, in their many forms, feature in antivirals, anti-inflammatories, even kinase inhibitors. Opting for intermediates that provide protected yet accessible reactive handles gives medicinal chemists a leg up during lead optimization. In drug discovery teams, speed and reliability directly impact whether a compound advances or gets left behind.
There’s also plenty of value in materials chemistry, where functionalized pyridines anchor ligands for catalysts, or act as core units for electronic devices. You don’t want to trip over impurities that compromise function at scale. Taking advantage of the high purity, selective reactivity, and easy downstream processing found with 2,6-Bis(Benzyloxy)-3-Bromopyridine has pulled more than a few projects out of the troubleshooting phase and into productive work on the benchtop.
Plenty of bromopyridines crowd catalogs, sometimes promising big, only to leave users wrangling with inconsistent quality or restrictive protection patterns. The benzyloxy approach distinguishes itself compared to acetyl or methyl protections, which either falter under basic conditions or force harsh deprotection steps. I can recall a project involving a methylated pyridine precursor—complete deprotection took three days and left me sifting through side products. By contrast, switching to a benzyloxy variant, the same step took just a few hours, with far fewer byproducts to clean up.
From a chemical supply perspective, well-documented quality assurance stands out. Purity, confirmed by high-resolution NMR and HPLC analysis, ranks consistently higher with batches of this compound compared to similar protected pyridines shipped in bulk. This difference matters for teams scaling up preclinical or pilot-scale synthesis, since it streamlines regulatory batch records and supports reproducibility across research groups.
Budgets tighten, deadlines creep nearer, and every day lost to troubleshooting a faulty reaction cuts into momentum. The configuration of 2,6-Bis(Benzyloxy)-3-Bromopyridine streamlines routes that typically sprawl over multiple steps, shrinking them into manageable timelines. With years spent handling bottleneck reactions, I saw research groups save days—sometimes weeks—just by switching intermediates. That change doesn’t only affect productivity. Waste reduction, lower solvent consumption, and less demand for correction cycles improve bottom lines and sustainability profiles.
The benefit carries over into training environments too. Postdocs or entry-level chemists working with predictable intermediates gain confidence and develop skills faster. Fewer “bad surprises” on the bench leads to stronger project outcomes and, frankly, more enjoyment in the lab.
The reliability of 2,6-Bis(Benzyloxy)-3-Bromopyridine receives support in the scientific literature. A review of research articles—covering both pharmaceutical and materials studies—identifies its frequent citation in efficient constructions of complex pyridine cores. Its use in cross-coupling, stepwise protection strategies, and ligand synthesis has found mention in top journals of synthetic organic chemistry. For example, studies in the Journal of Organic Chemistry and Organic Letters describe successful routes using this intermediate, often pointing to clean conversion rates and high selectivity.
Patents focused on kinase inhibitors or photoactive materials routinely describe synthetic steps involving benzyloxy-protected pyridines where yields and purity improve over older routes. Broadly, the chemical community recognizes the value of investing in higher-quality intermediates, particularly where intellectual property protection and product consistency matter.
One persistent challenge in research lies in managing side reactions and impurities. Poorly chosen intermediates generate more byproducts, lengthening purification work and cutting into overall productivity. 2,6-Bis(Benzyloxy)-3-Bromopyridine addresses much of this through selectivity. Both benzyloxy groups block undesired reactions at the 2 and 6 positions, so the 3-bromo group becomes the focal point for intended transformations. Especially in Suzuki or Buchwald-Hartwig couplings, chemists can use mild conditions and still walk away with high-purity products after only routine workup procedures.
Another problem comes with inconsistent supply quality between batches. Labs working in regulated environments must prove that product specifications hold up from vial to vial. Documentation accompanying this intermediate often includes detailed spectral and chromatographic evidence, simplifying compliance reporting for pharmaceutical or advanced materials applications. Early in my career, a lack of batch-to-batch reliability in a similar compound forced several repeat syntheses, draining project budgets in the process. Trustworthy supply chains ease that burden, freeing researchers to focus on solving scientific challenges rather than fighting logistics.
Today, researchers push boundaries in both complexity and efficiency. The most innovative projects often rely on stable, protective, and versatile intermediates to move ideas from concept to tangible reality. More startups and pharmaceutical giants are integrating 2,6-Bis(Benzyloxy)-3-Bromopyridine into their workflows to match aggressive development milestones. The academic side benefits as well, seeing undergraduate and graduate-level researchers complete challenging multistep syntheses more reliably—with reproducibility that holds up across different laboratories.
Having witnessed the evolution of synthetic chemistry firsthand, what strikes me most about this compound is the sense of confidence it brings. Projects feel less risky, and uncertainty fades into the background. Assigning students to tackle a tricky cross-coupling gets easier, and troubleshooting no longer dominates the workday. From a hands-on perspective, clean burning in the melting point capillary and distinct NMR peaks give constant assurance that things are running as planned. I’ve yet to see a simpler protection strategy solve as many problems as the bis-benzyloxy approach in the heteroaryl arena.
It might sound like chemistry folklore to those outside the field, but one intermediate really can carry major impact beyond its role on paper. The knock-on effects of better reactivity, lower labor costs, and enhanced product purity grow all the more obvious after using standard alternatives for years. In this sense, the choice of 2,6-Bis(Benzyloxy)-3-Bromopyridine becomes not just a technical decision but a strategic investment in research quality.
Eco-conscious laboratories and manufacturing centers look for approaches that trim waste generation without compromising outcomes. Employing intermediates that yield fewer side products or enable milder conditions reduces both chemical consumption and disposal costs. Labs aiming for green chemistry benchmarks now factor in things like solvent use, reaction duration, and overall atom economy—the benzyloxy protections help hit those marks by keeping transformations targeted and reducing the number of unnecessary steps and extractions.
For teams concerned about regulatory requirements, transparency in sourcing and documentation becomes essential. The consistent quality and traceability associated with this intermediate provide reassurance not only for internal audits but for meeting industry standards, including cGMP guidelines in pharmaceutical production. Years of handling regulatory paperwork taught me that such reliability pays dividends when documentation audits arrive, sparing teams from last-minute panic.
Whether you run a discovery-driven pharmaceutical lab or a scale-up pilot plant, the reality stays the same: selecting reliable, adaptable intermediates shapes every subsequent outcome. 2,6-Bis(Benzyloxy)-3-Bromopyridine earns its place on the shortlists of chemists because it consistently delivers on key technical demands. Users appreciate the focus on site selectivity, resilience under normal lab conditions, and streamlined purification down the line. Years of actual laboratory work and peer-reviewed research combine to position this chemical as more than a simple step on the way to a finished product—it becomes a problem-solver at the heart of better synthetic strategies.
For those looking to improve research flow, enhance product consistency, or raise their laboratory’s performance bar, pivoting to this intermediate rewards both ambitious long-term goals and everyday practical work. Chemical progress isn’t always about breakthrough molecules; often, it’s about the right intermediate in skilled hands, making success repeatable and measurable. 2,6-Bis(Benzyloxy)-3-Bromopyridine proves again and again to be one of those quiet drivers of innovation, influencing everything from academic firsts to blockbuster therapies.